List of Acorda Therapeutics, Inc. patents

Patents where

Current Assignee

Name

Acorda Therapeutics, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8734770 Methods and compositions for administration of TRPV1 agonists	Patent 8734770 was granted and assigned to Acorda Therapeutics, Inc. on May, 2014 by the United States Patent and Trademark Office.		Acorda Therapeutics, Inc.	United States Patent and Trademark Office	8734770	May 27, 2014
‌ US Patent 9198951 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure	Patent 9198951 was granted and assigned to Acorda Therapeutics, Inc. on December, 2015 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9198951	December 1, 2015
‌ US Patent 7037888 Methods for treating muscle diseases and disorders	Patent 7037888 was granted and assigned to Acorda Therapeutics, Inc. on May, 2006 by the United States Patent and Trademark Office.		Acorda Therapeutics, Inc.	United States Patent and Trademark Office	7037888	May 2, 2006
‌ US Patent 9549893 Compositions and kits for the removal of irritating compounds from bodily surfaces	Patent 9549893 was granted and assigned to Acorda Therapeutics, Inc. on January, 2017 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9549893	January 24, 2017
‌ US Patent 9468671 Compositions and methods for promoting neuronal outgrowth	Patent 9468671 was granted and assigned to Acorda Therapeutics, Inc. on October, 2016 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9468671	October 18, 2016
‌ US Patent 9528102 Proteoglycan degrading mutants for treatment of CNS	Patent 9528102 was granted and assigned to Acorda Therapeutics, Inc. on December, 2016 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9528102	December 27, 2016
‌ US Patent 9402886 Compositions and methods of using chondroitinase ABCI mutants	Patent 9402886 was granted and assigned to Acorda Therapeutics, Inc. on August, 2016 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9402886	August 2, 2016
‌ US Patent 11235031 Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure	Patent 11235031 was granted and assigned to Acorda Therapeutics, Inc. on February, 2022 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	11235031	February 1, 2022
‌ US Patent 9750707 Methods and compositions for administration of TRPV1 agonists	Patent 9750707 was granted and assigned to Acorda Therapeutics, Inc. on September, 2017 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9750707	September 5, 2017
‌ US Patent 9289501 Carbonate prodrugs and methods of using the same	Patent 9289501 was granted and assigned to Acorda Therapeutics, Inc. on March, 2016 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9289501	March 22, 2016
‌ US Patent 9839679 Methods of reducing extravasation of inflammatory cells	Patent 9839679 was granted and assigned to Acorda Therapeutics, Inc. on December, 2017 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9839679	December 12, 2017
‌ US Patent 9683000 Carbonate prodrugs and methods of using the same	Patent 9683000 was granted and assigned to Acorda Therapeutics, Inc. on June, 2017 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9683000	June 20, 2017
‌ US Patent 9024055 Acetaminophen conjugates, compositions and methods of use thereof	Patent 9024055 was granted and assigned to Acorda Therapeutics, Inc. on May, 2015 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9024055	May 5, 2015
‌ US Patent 8993545 Carbonate prodrugs and methods of using the same	Patent 8993545 was granted and assigned to Acorda Therapeutics, Inc. on March, 2015 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	8993545	March 31, 2015
‌ US Patent 9987340 Compositions and methods of using chondroitinase ABCI mutants	Patent 9987340 was granted and assigned to Acorda Therapeutics, Inc. on June, 2018 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9987340	June 5, 2018
‌ US Patent 9329171 Methods for detecting cardiac damage	Patent 9329171 was granted and assigned to Acorda Therapeutics, Inc. on May, 2016 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9329171	May 3, 2016
‌ US Patent 8236302 Compositions and methods of using chondroitinase ABCI mutants	Patent 8236302 was granted and assigned to Acorda Therapeutics, Inc. on August, 2012 by the United States Patent and Trademark Office.		Acorda Therapeutics, Inc.	United States Patent and Trademark Office	8236302	August 7, 2012
‌ US Patent 9272015 Method for achieving desired glial growth factor 2 plasma levels	Patent 9272015 was granted and assigned to Acorda Therapeutics, Inc. on March, 2016 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9272015	March 1, 2016
‌ US Patent 10717775 Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2		Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	10717775	July 21, 2020
‌ US Patent 9981998 Water-soluble acetaminophen analogs	Patent 9981998 was granted and assigned to Acorda Therapeutics, Inc. on May, 2018 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9981998	May 29, 2018
‌ US Patent 10258667 Methods for detecting cardiac damage	Patent 10258667 was granted and assigned to Acorda Therapeutics, Inc. on April, 2019 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	10258667	April 16, 2019
‌ US Patent 9744215 Method for achieving desired glial growth factor 2 plasma levels	Patent 9744215 was granted and assigned to Acorda Therapeutics, Inc. on August, 2017 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9744215	August 29, 2017
‌ US Patent 9757429 Methods for detecting cardiac damage	Patent 9757429 was granted and assigned to Acorda Therapeutics, Inc. on September, 2017 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9757429	September 12, 2017
‌ US Patent 8404232 Compositions and methods of using chondroitinase ABCI mutants	Patent 8404232 was granted and assigned to Acorda Therapeutics, Inc. on March, 2013 by the United States Patent and Trademark Office.		Acorda Therapeutics, Inc.	United States Patent and Trademark Office	8404232	March 26, 2013
‌ US Patent 9925173 Methods of using sustained release aminopyridine compositions	Patent 9925173 was granted and assigned to Acorda Therapeutics, Inc. on March, 2018 by the United States Patent and Trademark Office.	Acorda Therapeutics, Inc.	Acorda Therapeutics, Inc.	United States Patent and Trademark Office	9925173	March 27, 2018

Results per page:

58 results

0 selected

58 results

0 selected